IFN-γ and TNF-α decrease serotonin transporter function and expression in Caco2 cells

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 292, Issue 3, 2007, Pages

  Foley, Kevin F ^a   Pantano, Cristen ^a   Ciolino, Allison ^b   Mawe, Gary M ^a  

^a UNIVERSITY OF VERMONT   (United States)

^b FLETCHER ALLEN HEALTH CARE   (United States)

Author keywords

Colitis; Inflammation; Inflammatory bowel disease; Interferon; SERT; Tumor necrosis factor

Indexed keywords

FLUOXETINE; GAMMA INTERFERON; INTERLEUKIN 12; MESSENGER RNA; PROSTAGLANDIN E2; S NITROSOGLUTATHIONE; SEROTONIN TRANSPORTER; TRITIUM; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL STRAIN CACO 2; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INCUBATION TIME; IRRITABLE COLON; LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEROTONIN UPTAKE; ULCERATIVE COLITIS;

CACO-2 CELLS; CELL SURVIVAL; CULTURE MEDIA, CONDITIONED; EPITHELIAL CELLS; GENE EXPRESSION; HUMANS; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; LYMPHOCYTES; RNA, MESSENGER; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33947318947     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00470.2006     Document Type: Article

References (41)

1. Arango V, Underwood MD, Boldrini M, Tamir H, Kassir SA, Hsiung S, Chen JJ, Mann JJ. Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology 25: 892-903, 2001.
2. Borowsky B, Hoffman BJ. Neurotransmitter transporters: molecular biology, function, regulation. Int Rev Neurobiol 38: 139-199, 1995.
3. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3: 521-533, 2003.
4. Buyse M, Charrier L, Sitaraman S, Gewirtz A, Merlin D. Interferon-gamma increases hPepT1-mediated uptake of di-tripeptides including the bacterial tripeptide fMLP in polarized intestinal epithelia. Am J Pathol 163: 1969-1977, 2003.
5. Chen JJ, Li Z, Pan H, Murphy DL, Tamir H, Koepsell H, Gershon MD. Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: abnormal intestinal motility and the expression of cation transporters. J Neurosci 21: 6348-6361, 2001.
6. Coates MD, Johnson AC, Greenwood-Van Meerveld B, Mawe GM. Effects of serotonin transporter inhibition on gastrointestinal motility and colonic sensitivity in the mouse. Neurogastroenterol Motil 18: 464-471, 2006.
7. Coates MD, Mahoney CR, Linden DR, Sampson JE, Chen J, Blaszyk H, Crowell MD, Sharkey KA, Gershon MD, Mawe GM, Moses PL. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 126: 1657-1664, 2004.
8. Comes N, Gasull X, Gual A, Borras T. Differential expression of the human chloride channel genes in the trabecular meshwork under stress conditions. Exp Eye Res 80: 801-813, 2005.
9. Gershon MD. Nerves, reflexes, and the enteric nervous system: pathogenesis of the irritable bowel syndrome. J Clin Gastroenterol 39: S184-S193, 2005.
10. Gorard DA, Libby GW, Farthing MJ. 5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake. Gut 35: 496-500, 1994.
11. Gorard DA, Libby GW, Farthing MJ. Influence of antidepressants on whole gut and orocaecal transit times in health and irritable bowel syndrome. Aliment Pharmacol Ther 8: 159-166, 1994.
12. Grasset E, Bernabeu J, Pinto M. Epithelial properties of human colonic carcinoma cell line Caco-2: effect of secretagogues. Am J Physiol Cell Physiol 248: C410-C418, 1985.
13. Grasset E, Pinto M, Dussaulx E, Zweibaum A, Desjeux JF. Epithelial properties of human colonic carcinoma cell line Caco-2: electrical parameters. Am J Physiol Cell Physiol 247: C260-C267, 1984.
14. Gupta SK, Fitzgerald JF, Chong SK, Croffie JM, Garcia JG. Expression of inducible nitric oxide synthase (iNOS) mRNA in inflamed esophageal and colonic mucosa in a pediatric population. Am J Gastroenterol 93: 795-798, 1998.
15. Halleux C, Schneider YJ. Iron absorption by intestinal epithelial cells: 1. CaCo2 cells cultivated in serum-free medium, on polyethyleneterephthalate microporous membranes, as an in vitro model. In Vitro Cell Dev Biol 27A: 293-302, 1991.
16. Hendel J, Nielsen OH. Expression of cyclooxygenase-2 mRNA in active inflammatory bowel disease. Am J Gastroenterol 92: 1170-1173, 1997.
17. Hidalgo IJ, Raub TJ, Borchardt RT. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96: 736-749, 1989.
18. Holtmann MH, Neurath MF. Differential TNF-signaling in chronic inflammatory disorders. Curr Mol Med 4: 439-444, 2004.
19. Jayanthi LD, Samuvel DJ, Blakely RD, Ramamoorthy S. Evidence for biphasic effects of protein kinase C on serotonin transporter function, endocytosis, and phosphorylation. Mol Pharmacol 67: 2077-2087, 2005.
20. Lamb FS, Graeff RW, Clayton GH, Smith RL, Schutte BC, McCray PB Jr. Ontogeny of CLCN3 chloride channel gene expression in human pulmonary epithelium. Am J Respir Cell Mol Biol 24: 376-381, 2001.
21. Linden DR, Chen JX, Gershon MD, Sharkey KA, Mawe GM. Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol 285: G207-G216, 2003.
22. Linden DR, Foley KF, McQuoid C, Simpson J, Sharkey KA, Mawe GM. Serotonin transporter function and expression are reduced in mice with TNBS-induced colitis. Neurogastroenterol Motil 17: 565-574, 2005.
23. Magro F, Fraga S, Ribeiro T, Soares-da-Silva P. Decreased availability of intestinal dopamine in transmural colitis may relate to inhibitory effects of interferon-gamma upon L-DOPA uptake. Acta Physiol Scand 180: 379-386, 2004.
24. Martel F, Monteiro R, Lemos C. Uptake of serotonin at the apical and basolateral membranes of human intestinal epithelial (Caco-2) cells occurs through the neuronal serotonin transporter (SERT). J Pharmacol Exp Ther 306: 355-362, 2003.
25. Mawe GM, Coates MD, Moses PL. Review article: Intestinal serotonin signalling in irritable bowel syndrome. Aliment Pharmacol Ther 23: 1067-1076, 2006.
26. O'Hara JR, Ho W, Linden DR, Mawe GM, Sharkey KA. Enteroendocrine cells and 5-HT availability are altered in mucosa of guinea pigs with TNBS ileitis. Am J Physiol Gastrointest Liver Physiol 287: G998-G1007, 2004.
27. Pallone F, Monteleone G. Interleukin 12 and Th1 responses in inflammatory bowel disease. Gut 43: 735-736, 1998.
28. Pestka S, Krause CD, Walter MR. Interferons, interferon-like cytokines, and their receptors. Immunol Rev 202: 8-32, 2004.
29. Rojas-Cartagena C, Flores I, Appleyard CB. Role of tumor necrosis factor receptors in an animal model of acute colitis. Cytokine 32: 85-93, 2005.
30. Shamir R, Johnson WJ, Zolfaghari R, Lee HS, Fisher EA. Role of bile salt-dependent cholesteryl ester hydrolase in the uptake of micellar cholesterol by intestinal cells. Biochemistry 34: 6351-6358, 1995.
31. Singh P, Dai B, Yallampalli U, Lu X, Schroy PC. Proliferation and differentiation of a human colon cancer cell line (CaCo2) is associated with significant changes in the expression and secretion of insulin-like growth factor (IGF) IGF-II and IGF binding protein-4: role of IGF-II. Endocrinology 137: 1764-1774, 1996.
32. Spigset O. Adverse reactions of selective serotonin reuptake inhibitors: reports from a spontaneous reporting system. Drug Saf 20: 277-287, 1999.
33. Strober W, Kelsall B, Fuss I, Marth T, Ludviksson B, Ehrhardt R, Neurath M. Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation. Immunol Today 18: 61-64, 1997.
34. Travassos WJ, Cheifetz AS. Infliximab: use in inflammatory bowel disease. Curr Treat Options Gastroenterol 8: 187-196, 2005.
35. Ueno S. Genetic polymorphisms of serotonin and dopamine transporters in mental disorders. J Med Invest 50: 25-31, 2003.
36. Wade PR, Chen J, Jaffe B, Kassem IS, Blakely RD, Gershon MD. Localization and function of a 5-HT transporter in crypt epithelia of the gastrointestinal tract. J Neurosci 16: 2352-2364, 1996.
37. Wang J, Fu YX. Tumor necrosis factor family members and inflammatory bowel disease. Immunol Rev 204: 144-155, 2005.
38. Weizman A, Weizman R. Serotonin transporter polymorphism and response to SSRIs in major depression and relevance to anxiety disorders and substance abuse. Pharmacogenomics 1: 335-341, 2000.
39. Wheatcroft J, Wakelin D, Smith A, Mahoney CR, Mawe G, Spiller R. Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction. Neurogastroenterol Motil 17: 863-870, 2005.
40. Zhu CB, Blakely RD, Hewlett WA. The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology 31: 2121-2131, 2006.
41. Zhu CB, Hewlett WA, Feoktistov I, Biaggioni I, Blakely RD. Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent upregulation of serotonin transporters involves both transporter trafficking and activation. Mol Pharmacol 65: 1462-1474, 2004.